Discovering Genetic Biomarkers for Targeted Cancer Therapeutics with EXplainable Artificial Intelligence
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Millstein J, Budden T, Goode E, Anglesio M, Talhouk A, Intermaggio M
. Prognostic gene expression signature for high-grade serous ovarian cancer. Ann Oncol. 2020; 31(9):1240-1250.
PMC: 7484370.
DOI: 10.1016/j.annonc.2020.05.019.
View
2.
Bowtell D, Bohm S, Ahmed A, Aspuria P, Bast Jr R, Beral V
. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer. Nat Rev Cancer. 2015; 15(11):668-79.
PMC: 4892184.
DOI: 10.1038/nrc4019.
View
3.
Aghayev T, Mazitova A, Fang J, Peshkova I, Rausch M, Hung M
. IL27 Signaling Serves as an Immunologic Checkpoint for Innate Cytotoxic Cells to Promote Hepatocellular Carcinoma. Cancer Discov. 2022; 12(8):1960-1983.
PMC: 9357073.
DOI: 10.1158/2159-8290.CD-20-1628.
View
4.
Garsed D, Pandey A, Fereday S, Kennedy C, Takahashi K, Alsop K
. The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer. Nat Genet. 2022; 54(12):1853-1864.
PMC: 10478425.
DOI: 10.1038/s41588-022-01230-9.
View
5.
Shmatko A, Laleh N, Gerstung M, Kather J
. Artificial intelligence in histopathology: enhancing cancer research and clinical oncology. Nat Cancer. 2022; 3(9):1026-1038.
DOI: 10.1038/s43018-022-00436-4.
View